Myungjin Lee Selected Research

Myungjin Lee Research Topics

9	Neoplasms (Cancer) 01/2021 - 06/2009
2	Infections 01/2022 - 03/2005
2	Neoplasm Metastasis (Metastasis) 12/2016 - 06/2009
1	Hyperglycemia 04/2023
1	Laryngeal Neoplasms (Laryngeal Cancer) 10/2016
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2016
1	Venous Thromboembolism 12/2012
1	Carcinoma (Carcinomatosis) 12/2009
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2009
1	Melanoma (Melanoma, Malignant) 12/2009
1	Breast Neoplasms (Breast Cancer) 06/2009
1	Hemorrhage 06/2009
1	Non-alcoholic Fatty Liver Disease 06/2007
1	Iron Overload 06/2007
1	Hyperferritinemia 06/2007

3	Heparin (Liquaemin)FDA LinkGeneric 12/2012 - 06/2009
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 12/2016
2	AnticoagulantsIBA 12/2012 - 06/2009
2	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 12/2009 - 06/2009
1	Ringer's LactateIBA 04/2023
1	HES 130-0.4IBA 04/2023
1	Broadly Neutralizing AntibodiesIBA 01/2022
1	Tumor Biomarkers (Tumor Markers)IBA 12/2016
1	FurinIBA 10/2016
1	Indicators and Reagents (Reagents)IBA 10/2016
1	CateninsIBA 01/2016
1	MTOR InhibitorsIBA 07/2013
1	GalactosidasesIBA 07/2013
1	Sirolimus (Rapamycin)FDA Link 07/2013
1	Angiogenesis InhibitorsIBA 12/2012
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2009
1	Deoxycholic Acid (Sodium Deoxycholate)IBA 12/2009
1	Matrix Metalloproteinases (MMPs)IBA 12/2009
1	heparanaseIBA 12/2009
1	Therapeutic UsesIBA 06/2009
1	Transaminases (Aminotransferases)IBA 06/2007
1	Transferrin (beta 2 Transferrin)IBA 06/2007
1	Glucose (Dextrose)FDA LinkGeneric 06/2007
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 03/2005